Elsevier

Medical Hypotheses

Volume 44, Issue 3, March 1995, Pages 207-213
Medical Hypotheses

Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent

https://doi.org/10.1016/0306-9877(95)90137-XGet rights and content

Abstract

Ascorbic acid and its salts (AA) are preferentially toxic to tumor cells in vitro and in vivo. Given in high enough doses to maintain plasma concentrations above levels that have been shown to be toxic to tumor cells in vitro, AA has the potential to selectively kill tumor cells in a manner similar to other tumor cytotoxic chemotherapeutic agents. Most studies of AA and cancer to date have not utilized high enough doses of AA to maintain tumor cytotoxic plasma concentrations of AA. Data are presented which demonstrate the ability to sustain plasma levels of AA in humans above levels which are toxic to tumor cells in vitro and suggests the feasibility of using AA as a cytotoxic chemotherapeutic agent.

References (57)

  • L. Benade et al.

    Synergistic killing of Ehrlich ascites carcinoma cells by ascorbate and 3-amino-I, 2, 4triazole

    Oncology

    (1969)
  • S. Bram et al.

    Vitamin C preferential toxicity for malignant melanoma cells

    Nature

    (1980)
  • V. Noto et al.

    Effects of sodium ascorbate (vitamin C) and 2-methyl-1, 4-naphthoquinone (vitamin K3) treatment on human tumor cell growth in vitro

    Cancer

    (1989)
  • J. Helgestad et al.

    Characterization of a new malignant human T -cell line (PFI-285) sensitive to ascorbic acid

    Eur J Haematol

    (1990)
  • C.H. Park et al.

    Growth suppression of human leukemic cells in vitro by L-ascorbic acid

    Cancer Res

    (1980)
  • K. Yamafuji et al.

    Anti-tumor potency of ascorbic, dehydroascorbic, or 2,3-diketogulonic acid and their action on deoxyribonucleic acid

    Z Krebsforsch

    (1971)
  • K. Yagashita et al.

    Effects of tetraacetyl-bis-dehydroAA, a derivative of ascorbic acid, on Ehrlich cells and HeLa cells (human carcinoma cells)

    J Nutr Sci Vitaminol

    (1976)
  • C.J. Koch et al.

    Toxicity, radiation sensitivity modification, and metabolic effects of dehydroascorbate and ascorbate in mammalian cells

    J Cell Physiol

    (1978)
  • M.H. Cohen et al.

    Cure of advanced Lewis lung carcinoma (LL): a new treatment strategy

  • A. Lupulesco

    Vitamin C inhibits DNA, RNA and protein synthesis in epithelial neoplastic cells

    Intl J Vit Nutr Res

    (1991)
  • H.F. Pierson et al.

    Sodium ascorbate enhancement of carbidopa-levodopa methyl ester antitumor activity against pigmented B-16 melanoma

    Cancer Res

    (1983)
  • R.N. Chakrabarti et al.

    Effects of ascorbic acid on survival and cell-mediated immunity in tumor bearing mice

    IRCS Med Sci

    (1984)
  • C.S. Tsao et al.

    In vivo antineoplastic activity of ascorbic acid for human mammary tumor

    In vivo

    (1988)
  • E. Cameron et al.

    Ascorbic acid and cancer: a review

    Cancer Res

    (1979)
  • R. Anderson

    Vitamin C and immune functions: mechanisms of immunostimulation

  • D.E. Henson et al.

    Ascorbic acid: biologic functions and relation to cancer: commentary

    JNCI

    (1991)

    • Cited by (0)

    View full text
    Copyright © 1995 Published by Elsevier Ltd.